Public Availability of Advisory Committee Members' Financial Interest Information and Waivers: Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Information
Type
Guidance
Regulated products
Animal & Veterinary, Biologics, Cosmetics, Dietary Supplements, Drugs, Food & Beverages, Medical Devices, Radiation-Emitting Products, Tobacco
Topics
Advisory Committees
Published
February 28, 2014
Last updated
April 20, 2019
Description
This document provides guidance on the public availability of financial interest information and waivers for FDA advisory committee members.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)